Breast Cancer Research and Treatment

, Volume 25, Issue 1, pp 73–82 | Cite as

Structural and functional studies of insulin receptors in human breast cancer

  • Lucia Frittitta
  • Riccardo Vigneri
  • Vincenzo Papa
  • Ira D. Goldfine
  • Giuseppe Grasso
  • Vincenzo Trischitta


We characterized the structure and the function of insulin receptors isolated from 10 human breast cancer specimens. We observed that the insulin receptor content, as determined by a specific radioimmunoassay, was four fold increased in human breast cancer tissue when compared to normal breast tissues. In both cancer and normal breast tissues, insulin receptor mRNA consisted of two major species of approximately 11.0 and 8.5 kilobases. The size of the insulin receptor alpha subunit was determined by125I-insulin cross-linking followed by immunoprecipitation and polyacrylamide gel electrophoresis; a value of 135 kDa was observed for receptors from both breast cancer and normal breast tissues. The functional binding ability of insulin receptors from cancer tissues was slightly lower as compared to normal tissue derived insulin receptor (% B/T= 2.22±0.50 per ng of insulin receptor as determined by radioimmunoassay vs. 2.96±0.49, mean±S.E.M.). The concentration of insulin that caused half maximal inhibition of125I-insulin binding was very similar for both cancer and normal breast receptors (80pM).

The size of the insulin receptor beta subunit as determined by receptor autophosphorylation was 95kDa. Basal and maximal insulin (100nM) stimulated receptor tyrosine kinase activity, in terms of both receptor autophosphorylation and phosphorylation of an exogenous substrate, was similar in malignant and normal breast tissue derived insulin receptor. Also, a very similar insulin stimulated Km value for ATP was showed by the tyrosine kinase of insulin receptors from breast cancer and normal breast tissue (11.1 and 10.8µM ATP, respectively). However, in insulin receptors from breast cancer tissue the average tyrosine kinase sensitivity to insulin, as calculated on the exogenous substrate, was higher, although not significantly, with respect to normal breast tissue (ED50 at 0.28±0.09 and 1.08±0.33 nM insulin, respectively). A similarly different sensitivity to insulin was observed also for receptor autophosphorylation.

In conclusion, this study demonstrates that breast cancer tissues have an increased number of structurally and functionally normal insulin receptors. In some breast cancer tissues, however, the sensitivity of the receptor tyrosine kinase activity to insulin is greatly increased. These data suggest that, in vivo, the mitogenic effect of insulin may play a role in the biology of certain breast cancers.

Key words

growth factors insulin sensitivity oncogenes receptor growth factors tyrosine kinase 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Yarden Y, Ullrich A: Growth factor receptor tyrosine kinases. Ann Rev Biochem 57: 443–478, 1988Google Scholar
  2. 2.
    Ullrich A, Schlessinger J: Signal transduction by receptors with tyrosine-kinase activity. Cell 61: 203–212, 1990Google Scholar
  3. 3.
    Cross M, Dexter TM: Growth factors in development, transformation and tumorigenesis. Cell 64: 271–280, 1991Google Scholar
  4. 4.
    Kaleko M, Rutter WJ, Miller AD: Overexpression of the human insulin-like growth factor I receptor promotes ligand-dependent neoplastic transformation. Mol Cell Biol 10: 464–473, 1990Google Scholar
  5. 5.
    Di Fiore PP, Pierce JH, Fleming TP, Hazan R, Ullrich A, King CR, Schlessinger J, Aaronson SA: Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cells. Cell 51: 1063–1070, 1987Google Scholar
  6. 6.
    Giorgino F, Belfiore A, Milazzo G, Costantino A, Maddux B, Whittaker J, Goldfine ID, Vigneri R: Overexpression of insulin receptor in fibroblasts and ovary cells induces a ligand-mediated transformed phenotype. Mol Endocrinol 5: 452–459, 1991Google Scholar
  7. 7.
    Roussel MF, Dull TJ, Rettenmier CW, Ralph P, Ullrich A, Sherr CJ: Transforming potential of the c-fms protooncogene (CSF-1 receptor). Nature (London) 325: 549–552, 1987Google Scholar
  8. 8.
    Bargmann CI, Hung MC, Weinberg RA: Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185. Cell 45: 649–657, 1986Google Scholar
  9. 9.
    Hudziak RM, Schlessinger J, Ullrich A: Increased expression of the putative growth factor receptor p185 HER2 causes transformation and tumorigenesis of NIH 3T3 cells. Proc Natl Acad Sci USA 84: 7159–7163, 1987Google Scholar
  10. 10.
    Goldfine ID: The insulin receptor: molecular biology and transmembrane signalling. Endocr Rev 8: 235–255, 1987Google Scholar
  11. 11.
    Ullrich A, Bell JR, Chen EY, Herrera P, Petruzzelli LM, Dull TJ, Gray A, Coussens L, Liao YC, Tsubokawa M, Mason A, Seeburg PH, Grunfeld C, Rosen OM, Ramachandran J: Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes. Nature (London) 313: 756–761, 1985Google Scholar
  12. 12.
    Straus DS: Growth-stimulatory actions of insulinin vitro andin vivo. Endocr Rev 5: 356–369, 1984Google Scholar
  13. 13.
    Osborne CK, Bolan G, Monaco ME, Lippmann ME: Hormone responsive human breast cancer in long term tissue culture: effect of insulin. Proc Natl Acad Sci USA 73: 4536–4540, 1976Google Scholar
  14. 14.
    Mountjoy KG, Holdaway IM, Finlay GJ: Insulin receptor regulation in cultured human tumor cells. Cancer Res 43: 4537–4542, 1983Google Scholar
  15. 15.
    Van Der Burg B, Rutteman GR, Blankestein MA, De Laat SW, Van Zoelen EJJ: Mitogenic stimulation of human breast cancer cells in a growth factor-defined medium: synergistic action of insulin and estrogen. J Cell Physiol 134: 101–108, 1988Google Scholar
  16. 16.
    Papa V, Pezzino V, Costantino A, Belfiore A, Giuffrida D, Frittitta L, Vannelli GB, Brand R, Goldfine ID, Vigneri R: Elevated insulin receptor content in human breast cancer. J Clin Invest 86: 1503–1510, 1990Google Scholar
  17. 17.
    Forsayeth JR, Montemurro A, Maddux BA, De Pirro R, Goldfine ID: Effect of monoclonal antibodies on human insulin receptor autophosphorylation, negative cooperativity and down regulation. J Biol Chem 262: 4134–4140, 1987Google Scholar
  18. 18.
    Pezzino V, Papa V, Trischitta V, Brunetti A, Goodman PA, Treutelaar MK, Williams JA, Vigneri R, Goldfine ID: Human insulin receptor radioimmunoassay: applicability to insulin-resistant states. Am J Physiol 257: E451–457, 1989Google Scholar
  19. 19.
    Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the folin phenol reagent. J Biol Chem 193: 265–275, 1951Google Scholar
  20. 20.
    Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY, 1989Google Scholar
  21. 21.
    Papa V, Reese CC, Brunetti A, Vigneri R, Siiteri PK, Goldfine ID: Progestins increase insulin receptor content and insulin stimulation of growth in human breast carcinoma cells. Cancer Res 50: 7858–7862, 1990Google Scholar
  22. 22.
    Hawley DM, Maddux BA, Patel RG, Wong KY, Mamula PW, Firestone GL, Brunetti A, Verspohl E, Goldfine ID: Insulin receptor monoclonal antibodies that mimic insulin action without activating tyrosine kinase. J Biol Chem 264: 2438–2444, 1989Google Scholar
  23. 23.
    Milazzo G, Giorgino F, Damante G, Sung C, Stampfer MR, Vigneri R, Goldfine ID, Belfiore A: Insulin receptor expression and function in human breast cancer cell lines. Cancer Res 52: 3924–3930, 1992Google Scholar
  24. 24.
    Steele-Perkins G, Roth R: Insulin-mimetic anti-insulin receptor monoclonal antibodies stimulate receptor kinase activity in intact cells. J Biol Chem 265: 9458–9463, 1990Google Scholar

Copyright information

© Kluwer Academic Publishers 1993

Authors and Affiliations

  • Lucia Frittitta
    • 2
  • Riccardo Vigneri
    • 2
  • Vincenzo Papa
    • 2
  • Ira D. Goldfine
    • 1
  • Giuseppe Grasso
    • 2
  • Vincenzo Trischitta
    • 2
  1. 1.Diabetes and Endocrine Research, Mount Zion Medical Center, and Department of Medicine and PhysiologyUniversity of California San FranciscoSan FranciscoUSA
  2. 2.Cattedra di Endocrinologia e Patologia CostituzionaleUniversità di Catania, Ospedale GaribaldiCataniaItaly

Personalised recommendations